会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHOD FOR MEASURING CYSTATIN C IN HUMAN BODY FLUID
    • 人体体液中CYSTATIN C的测定方法
    • US20110236996A1
    • 2011-09-29
    • US13132790
    • 2009-12-03
    • Shinya NakayamaHiroshi TakahashiYasushi NakamuraTomo Shimizu
    • Shinya NakayamaHiroshi TakahashiYasushi NakamuraTomo Shimizu
    • G01N33/68
    • G01N33/543G01N33/6893G01N2333/8139
    • There is provided a particle-enhanced immunoassay method for cystatin C in a human body fluid, which has higher specificity and is easily automatable at low cost as compared with conventional assay methods that use large amounts of polyclonal antibodies having low specificity or monoclonal antibodies having high specificity but having poor agglutinability.Disclosed is an assay method specific to cystatin C in a human body fluid, which is a particle-enhanced immunoassay method utilizes a combination of antibody-coated particles in which some insoluble carrier particles are coated with anti-human cystatin C monoclonal antibodies of one type which have high affinity and in which some other insoluble carrier particles are coated with anti-human cystatin C monoclonal antibodies of one type which recognize an epitope different from that of the monoclonal antibody of the first-mentioned type and which have relatively low affinity, wherein the binding amount of the anti-human cystatin C monoclonal antibodies relative to the total weight of the particles being coated with the corresponding antibodies is less than 5% by weight.
    • 与使用大量具有低特异性的多克隆抗体或具有高特异性的单克隆抗体的常规测定方法相比,提供了人体液中半胱氨酸蛋白酶抑制剂C的微粒增强免疫测定方法,其具有更高的特异性并且可以以低成本容易地自动化 特异性但具有差的凝集性。 本发明公开了一种人体液中半胱氨酸蛋白酶抑制剂C特异性检测方法,其是使用抗体包被的颗粒的组合,其中一些不溶性载体颗粒被一种类型的抗人半胱氨酸蛋白酶抑制剂C单克隆抗体包被, 其具有高亲和力,并且其中一些其它不溶性载体颗粒被一种类型的抗人半胱氨酸蛋白酶抑制剂C单克隆抗体包被,所述抗人半胱氨酸蛋白酶抑制剂C单克隆抗体识别与第一类型的单克隆抗体的表位不同并具有相对低亲和力的表位,其中 抗人半胱氨酸蛋白酶抑制剂C单克隆抗体相对于被相应抗体包被的颗粒的总重量的结合量小于5重量%。
    • 2. 发明授权
    • Method for measuring cystatin C in human body fluid
    • 人体液体中半胱氨酸蛋白酶抑制剂C的测定方法
    • US08802446B2
    • 2014-08-12
    • US13132790
    • 2009-12-03
    • Shinya NakayamaHiroshi TakahashiYasushi NakamuraTomo Shimizu
    • Shinya NakayamaHiroshi TakahashiYasushi NakamuraTomo Shimizu
    • G01N33/543
    • G01N33/543G01N33/6893G01N2333/8139
    • Provided is a method and reagent for measuring cystatin C in a human body fluid, by contacting a human body fluid with (a) first insoluble carrier particles coated with a first anti-human cystatin C monoclonal antibody and (b) second insoluble carrier particles coated with a second anti-human cystatin C monoclonal antibody, where the first anti-human cystatin C monoclonal antibody has an affinity for cystatin C that is higher than the second anti-human cystatin C monoclonal antibody, the second anti-human cystatin C monoclonal antibody recognizes an epitope of cystatin C that is different from the epitope recognized by the first anti-human cystatin C monoclonal antibody, and the first and second insoluble carrier particles are coated with from 1% to less than 4% by weight of the anti-human cystatin C monoclonal antibodies.
    • 本发明提供一种通过使人体液与(a)涂覆有第一抗人半胱氨酸蛋白酶抑制剂C单克隆抗体的第一不溶性载体颗粒和(b)涂覆有第一抗人半胱氨酸蛋白酶抑制剂C单克隆抗体的第二不溶性载体颗粒接触来测量人体液体中的半胱氨酸蛋白酶抑制剂C的方法和试剂 使用第二抗人半胱氨酸蛋白酶抑制剂C单克隆抗体,其中第一抗人半胱氨酸蛋白酶抑制剂C单克隆抗体对半胱氨酸蛋白酶抑制剂C具有高于第二抗人半胱氨酸蛋白酶抑制剂C单克隆抗体的亲和力,第二抗人半胱氨酸蛋白酶抑制剂C单克隆抗体 识别与由第一抗人半胱氨酸蛋白酶抑制剂C单克隆抗体识别的表位不同的半胱氨酸蛋白酶抑制剂C的表位,并且第一和第二不溶性载体颗粒涂覆有1%至小于4重量%的抗人 半胱氨酸蛋白酶抑制剂C单克隆抗体。